LOTUS PHARMACEUTICAL..........

Satz 26-06

Datum Erster Hoch Tief Schluss     Stücke Volumen
26.06.13 0,03 0,03 0,02  0,0299 $ 1.100 28

GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
01.07.13 0,019 0,0299 0,019  0,0299 $ 600 17
GrB  

Zeit  Kurs  Stück  
19:46:15 0,029 $  500  
15:30:13 0,021 $  10.000
____________________
GRATULATION  

bekommt auch

Zeit  Kurs  Stück  
15:56:10 0,03 $  500

so sind die Regeln ..und GLÜCKWUNSCH  

ich das buran bin ein kleiner Russen Schizo Wicht ..ein klein bludy fucky terrorist ..das kannst Du auch ..oben links in der Übersicht steht die WKN ..nimm sie Dir ..hau sie in Dein Bunker rein ..komm und mach hier mit ..ich Deine Russencindy bin hier so allein

Datum Erster Hoch Tief Schluss     Stücke Volumen
05.08.13 0,03 0,03 0,03  0,03 $ 500 15

Russencindy buran  

Du hast den neuen Duft von GEeeeeeeeeSTONK

Datum Erster Hoch Tief Schluss     Stücke Volumen
08.08.13 0,0319 0,032 0,03  0,03 $ 41.092 1.281



LOTUS PHARMACEUTICAL & buran  

Datum Erster Hoch Tief Schluss     Stücke Volumen
05.09.13 0,0111 0,03 0,0111  0,0299 $ 7.000 97

GrB  

Bucheinsicht

Zeit  Kurs  Stück  
15:31:04 0,03 $  500
_________________
GRATULATION eine schöne erfolgreich ausgeführte Kauforder

und die Tickerschluss Lampe::: 0,03 $ +147,93% +0,0179 $ In Euro: 0,0225 €

buran,Der Börsen Wand SCHEISSER  

Datum Erster Hoch Tief Schluss     Stücke Volumen
25.09.13 0,0131 0,0182 0,0131  0,0182 $ 4.150 59

GrB  

manufactures, and sells pharmaceuticals in the People?s Republic of China. The company markets valsartan capsules under the Maixin name to treat hypertension; eye drops under the Muxin name to treat glaucoma; and Octreotide Acetate Injection solution under the Yipubishan name for treating gastric ulcers. It also offers Junxin branded Levofloxacin, an anti-bacterial drug for the treatment of mild, moderate, and severe infections caused by susceptible trains of the designated microorganisms in the conditions such as acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections, complicated and uncomplicated urinary tract infections, and acute pyelonephritis; and Nicergoline for Injection, an a-receptor blockage nerve system blood-brain medicine. The company's products under development include R-Bambuterol-Class 1 for the treatment of asthma; Gliclazide-controlled release tablets for the treatment of diabetes; Isosorbide Mononitrate-tablets for the treatment of cardiovascular-coronary artery; Verapamil Hydrochloride tablets for the treatment of cardiovascular-irregular angina; and Lovastatin tablets, Valsartan-controlled release tablets, and Hawthorn Flavonoids tablets for the treatment of cardiovascular-hyperlipemia. It also involves in retailing Western and traditional Chinese medications, and medical treatment equipment through 10 retail pharmacy locations; performing research and development, and lab testing projects for third parties; and leasing retail space to licensed physicians, and merchants in the retail pharmacies. The company sells its products through a nationwide sales network to hospitals, clinics, and drugs stores. Lotus Pharmaceuticals, Inc. is based in Beijing, the People?s Republic of China.
http://finance.yahoo.com/q/pr?s=LTUS  

Lotus Pharmaceuticals, Inc.
16 Cheng Zhuang Road
Feng Tai District
Beijing, 100071
China - Map
Phone: 86 10 6389 9868
Fax: 86 10 6389 9867
Website: http://www.lotuspharma.com

http://finance.yahoo.com/q/pr?s=LTUS  

http://finance.yahoo.com/q/h?s=LTUS+Headlines GrB  

Data provided by Capital IQ, except where noted.
Valuation Measures  
Market Cap (intraday)5: 506.25K
Enterprise Value (Sep 26, 2013)3: 6.58M
Trailing P/E (ttm, intraday): 0.29
Forward P/E (fye Dec 31, 2012)1: N/A
PEG Ratio (5 yr expected)1: N/A
Price/Sales (ttm): 0.01
Price/Book (mrq): 0.01
Enterprise Value/Revenue (ttm)3: 0.09
Enterprise Value/EBITDA (ttm)6: 0.64

Financial Highlights  
Fiscal Year
Fiscal Year Ends: Dec 31
Most Recent Quarter (mrq): Sep 30, 2011

Profitability
Profit Margin (ttm): 2.43%
Operating Margin (ttm): 11.44%

Management Effectiveness
Return on Assets (ttm): 4.56%
Return on Equity (ttm): 1.82%

Income Statement
Revenue (ttm): 71.39M
Revenue Per Share (ttm): 2.60
Qtrly Revenue Growth (yoy): 4.00%
Gross Profit (ttm): 39.78M
EBITDA (ttm)6: 10.31M
Net Income Avl to Common (ttm): 1.72M
Diluted EPS (ttm): 0.06
Qtrly Earnings Growth (yoy): -81.30%

Balance Sheet
Total Cash (mrq): 158.91K
Total Cash Per Share (mrq): 0.01
Total Debt (mrq): 6.18M
Total Debt/Equity (mrq): 6.22
Current Ratio (mrq): 0.53
Book Value Per Share (mrq): 3.58

Cash Flow Statement
Operating Cash Flow (ttm): 18.37M
Levered Free Cash Flow (ttm): -5.29M

Trading Information  
Stock Price History
Beta: N/A
52-Week Change3: 100.00%
S&P500 52-Week Change3: 16.97%
52-Week High (Apr 5, 2013)3: 0.15
52-Week Low (Sep 25, 2013)3: 0.01
50-Day Moving Average3: 0.03
200-Day Moving Average3: 0.03

Share Statistics
Avg Vol (3 month)3: 7,427
Avg Vol (10 day)3: 5,638
Shares Outstanding5: 27.82M
Float: N/A
% Held by Insiders1: 49.89%
% Held by Institutions1: 0.40%
Shares Short 3: N/A
Short Ratio 3: N/A
Short % of Float 3: N/A
Shares Short (prior month)3: N/A

Dividends & Splits
Forward Annual Dividend Rate4: N/A
Forward Annual Dividend Yield4: N/A
Trailing Annual Dividend Yield3: N/A
Trailing Annual Dividend Yield3: N/A
5 Year Average Dividend Yield4: N/A
Payout Ratio4: N/A
Dividend Date3: N/A
Ex-Dividend Date4: N/A
Last Split Factor (new per old)2: 1:2
Last Split Date3: Dec 31, 2010

http://finance.yahoo.com/q/ks?s=LTUS+Key+Statistics  

Datum Erster Hoch Tief Schluss     Stücke Volumen
11.10.13 0,0152 0,027 0,0152  0,027 $ 1.000 22

Kosmonova buran  

SK 0,027 $ SKP -10,00 Pott +136,84% ,GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
  06.11.13      0,03      0,03§0,03 0,03 $ 10.000 300

GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
  14.11.13     0,021    0,0282§0,021 0,0282 $ 8.000 0

..und nicht an dem was Du haben könntest ..buran und MfG  

Zeit  Kurs Stück
15:33:49 0,0274 $ 500
15:30:09 0,0199 $ 500
___________________
GRATULATION  

:::::::::::::: 0,0279 $ +1,82% +0,0005 $
In Euro: 0,0205 € | Nasdaq OTC Other, 27.11.13 ,GrB  

Zeit    Kurs Stück
  15:57:26§0,0152 $ 1.050
____________________
GRATULATION          §
 

:::::::::::::::: 0,0167 $ +9,87% +0,0015 $
In Euro: 0,0122 € | Nasdaq OTC Other, 13.01.14:::::: musse auch ma machen ..::FUNFAKTOR 1000

buran,Die Börsen LOTUS PHARMACEUTICAL Grüne Lampen Posterin
 

Datum Erster Hoch Tief Schluss     Stücke Volumen
  17.01.14     0,016     0,016§0,016 0,016 $ 1.000 16
  16.01.14    0,0228     0,023§0,016 0,016 $ 140.000 3.174
  15.01.14    0,0156    0,0156§0,0156 0,0156 $ 5.415 84
  14.01.14    0,0156     0,016§0,0156 0,016 $ 9.000 144
  13.01.14    0,0167    0,0167§0,0167 0,0167 $ 375 6
  10.01.14    0,0111    0,0212§0,0111 0,0152 $ 1.750 28
  08.01.14    0,0229    0,0229§0,0229 0,0229 $ 61.500 1.409
  07.01.14    0,0152    0,0152§0,0152 0,0152 $ 1.050 16
  06.01.14    0,0151    0,0151§0,0151 0,0151 $ 2.500 38
  03.01.14    0,0229    0,0229§0,0229 0,0229 $ 3.500 80

GrB  

Datum Erster Hoch Tief Schluss     Stücke Volumen
27.02.14 0,02 0,02 0,02  0,02 $ 200 4
26.02.14 0,0245 0,0245 0,02  0,0245 $ 14.000 305
25.02.14 0,0175 0,0245 0,0175  0,0245 $ 53.734 1.309
21.02.14 0,017 0,017 0,017  0,017 $ 2.165 37
19.02.14 0,0161 0,0161 0,0161  0,0161 $ 250 4
11.02.14 0,02 0,02 0,02  0,02 $ 19.875 397
07.02.14 0,0161 0,02 0,0161  0,02 $ 15.311 303
04.02.14 0,021 0,021 0,021  0,021 $ 2.000 42

buran und MfG und danke und weitermachen  

:::::::::::::::::: 0,0248 $ +55,00% +0,0088 $
In Euro: 0,0180 € | Nasdaq OTC Other, 15.04.14:::::::: buran und MfG und EDELMÄDEL  

SK 0,016 $ SKP +0,00 Pott +40,35% ,GrB